Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Carfostin by Asklepios BioPharmaceutical for Congestive Heart Failure (Heart Failure): Likelihood of Approval
Carfostin is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Congestive Heart Failure (Heart Failure). According...
Data Insights
Carfostin by Asklepios BioPharmaceutical for Non-ischemic Cardiomyopathy: Likelihood of Approval
Carfostin is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Non-ischemic Cardiomyopathy. According to GlobalData, Phase...